Executive Summary
Biopharma has invested heavily in patient engagement. Hubs, specialty pharmacies, copay programs, digital health platforms, nurse ambassador networks, patient advocacy partnerships — the infrastructure is substantial. Yet therapy discontinuation rates remain stubbornly high, unexplained drop-offs continue to confound commercial teams, and the gap between enrollment and sustained adherence is the most expensive problem most brands are not solving systematically.
This guide addresses the structural reason those investments underperform: they are designed to optimize activation, not persistence. Most patient engagement programs address the 10% of the patient journey that biopharma can see clearly — enrollment, first fill, initial training. The 90% — daily medication decisions, side-effect management, refill navigation, life disruption — happens beyond the reach of any single hub or vendor.
Closing that gap requires a fundamentally different approach: comprehensive patient engagement programs built on ecosystem mapping, proactive outreach workflows, and cross-vendor care coordination. This guide shows you how to design one.
The 90/10 Framework
Most biopharma programs invest 70% of patient support budget on the 10% of the journey that leads to first fill. The remaining 90% — where persistence is actually determined — receives 30%. Comprehensive patient engagement programs invert this logic: they build infrastructure for the full journey, using ecosystem mapping to identify where the 90% breaks down and proactive outreach to intervene before it does.
The State of Patient Engagement Programs in 2026
The biopharma patient engagement landscape in 2026 is characterized by a paradox: more investment, more vendors, more technology — and persistent problems with unexplained discontinuation. Understanding why requires stepping back from individual point solutions and examining the structural architecture of most programs.
The fundamental problem is architectural. Patient engagement programs grew up sequentially: a hub was added to solve access, a specialty pharmacy to handle distribution, a copay program to remove cost barriers, a digital platform to improve education, a nurse network for clinical support. Each addition was logical in isolation. Together, they created a fragmented ecosystem with multiple handoff points — and no one accountable for what happens between them.
Why Point Solutions Aren't Enough
Each point solution in your patient support ecosystem was designed to optimize its own scope. Your hub measures enrollment rates and call resolution. Your specialty pharmacy tracks fill rates and days on therapy. Your copay program reports on copay card activations. Your digital platform shows engagement metrics.
What none of them report: what happened to the patient in the gaps between their involvement. The 72 hours between hub PA approval and specialty pharmacy shipment. The four weeks between injection training and the first refill conversation. The weekend when a patient couldn't reach anyone and made a quiet decision to stop.
"Five excellent point solutions can still produce multiple handoff failures. The problem isn't the quality of each vendor — it's the absence of infrastructure for what happens between them."
What Is a Comprehensive Patient Engagement Program?
A comprehensive patient engagement program is a coordinated patient support architecture that spans the full treatment journey — from pre-enrollment awareness through sustained on-therapy support — with defined accountability for every patient transition point.
It is distinguished from a standard patient support program by three characteristics:
- Full-journey scope: It covers activation AND sustained support, with defined infrastructure for the 90% of the journey that happens between formal engagement touchpoints.
- Cross-vendor coordination: It manages patient transitions across all support vendors — hub, pharmacy, copay, digital, clinical — with explicit handoff accountability and unified visibility.
- Proactive outreach model: It deploys outreach based on predictive risk signals and journey triggers, not reactive response to patient-initiated contact.
Core Components of a Comprehensive Program
| Component | What It Does | Coverage |
|---|---|---|
| Ecosystem Mapping | Maps all stakeholders, vendors, and handoff points across the full patient journey | Full Journey |
| Patient Access Support | Benefits verification, prior authorization management, appeals | Activation |
| Proactive Outreach Workflows | Trigger-based outreach at refill windows, handoff events, at-risk signals | Sustained 90% |
| Care Coordination | Cross-vendor coordination of patient transitions, clinical support, SDOH navigation | Full Journey |
| Digital Engagement | Patient education, adherence reminders, self-service tools | Sustained 90% |
| Population Health Analytics | At-risk patient stratification, discontinuation prediction, outcome tracking | Full Journey |
| Cross-Vendor Measurement | Unified journey KPIs beyond individual vendor scorecards | Full Journey |
Understanding the Full Patient Ecosystem
Before you can map a patient ecosystem, you need a complete picture of who and what is in it. Most biopharma teams underestimate the number of actors involved in a patient's treatment journey — and significantly underestimate the number of handoff points where patients can fall through.
The Five Layers of the Patient Ecosystem
Layer 1: Clinical Care Network
Prescribing HCPs, specialist offices, infusion centers, primary care physicians, nurse practitioners, and clinical coordinators. This layer initiates the treatment journey but has limited visibility into what happens after the patient leaves the office.
Layer 2: Patient Access Infrastructure
Hub services, benefits investigation vendors, prior authorization management, appeals support, copay programs, patient assistance programs, and free drug programs. This layer manages the access barrier — but its accountability typically ends at first fill approval.
Layer 3: Distribution & Dispensing
Specialty pharmacies, limited distribution drug networks, mail-order fulfillment, cold chain logistics, and infusion providers. This layer handles physical product delivery but operates independently from the access and clinical layers in most programs.
Layer 4: Support & Education
Nurse ambassador networks, patient education programs, digital health platforms, remote monitoring tools, patient portals, and disease state education content. This layer provides clinical and educational support but often lacks integration with access and distribution data.
Layer 5: Community & Social Infrastructure
Patient advocacy organizations, caregiver networks, peer support groups, social determinants of health (SDOH) resources, transportation assistance, and housing support. This layer addresses the non-clinical factors that most influence real-world adherence — and is the least systematically integrated into commercial patient engagement programs.
Patients Don't Experience Layers — They Experience Handoffs
Your patient doesn't know or care which layer is responsible for which task. They experience a seamless journey or they experience friction. Every transition between layers — Layer 2 to Layer 3, Layer 3 to Layer 4 — is a handoff point that can fail silently. Ecosystem mapping makes those transitions visible and accountable.
The 5-Step Ecosystem Mapping Methodology
Ecosystem mapping, as applied to patient engagement programs, is a structured process that identifies every stakeholder, vendor, and transition point in a patient's treatment journey — and scores each handoff point for accountability, visibility, and failure risk. It is the diagnostic foundation for everything that follows: outreach design, care coordination, and measurement.
Stakeholder Inventory
Document every entity that touches the patient across all five ecosystem layers — including informal touchpoints often omitted from vendor maps (caregivers, pharmacist counseling, disease-state communities). Assign each stakeholder a role type (clinical, access, distribution, support, community) and a current data-sharing status with your program.
Journey Stage Mapping
Map the patient journey chronologically: awareness → diagnosis → referral → enrollment → benefit verification → PA → first fill → injection training → refill 1 → sustained on-therapy → off-therapy decision. For each stage, document which stakeholders are active, what the patient needs, and what success looks like.
Handoff Point Identification
Identify every point where accountability or communication transfers between stakeholders. Score each handoff on three dimensions: clarity (is it clear who owns the next step?), speed (is there a defined timeline?), and visibility (does your program know when the handoff succeeds or fails?). Low-scoring handoffs are your highest discontinuation risk points.
Influence & Intervention Mapping
For each stage and stakeholder, identify the interventions currently deployed and the gaps. Where do patients receive support? Where do they navigate alone? Which at-risk moments have no outreach trigger? This step produces your intervention gap map — the blueprint for proactive outreach workflow design.
Data Integration Assessment
Evaluate what data is currently flowing between ecosystem layers — and what isn't. Identify where patient signals are generated but not shared (e.g., specialty pharmacy refill data not feeding back to hub; patient portal engagement data not integrated with outreach timing). This assessment drives your cross-vendor data architecture decisions.
Designing Proactive Patient Outreach Workflows
Proactive patient outreach is the operational backbone of comprehensive patient engagement programs. It is the shift from waiting for patients to call — to reaching patients at the right moment, before a decision to discontinue becomes irreversible.
The Four Categories of Outreach Triggers
Journey-Stage Triggers
Outreach automatically initiated at predictable high-risk moments in the patient journey: first refill window (day 25–28 of a monthly therapy), the 90-day 'dropout cliff' common in specialty conditions, the transition from injection training to self-administration.
Handoff-Event Triggers
Outreach initiated when a cross-vendor handoff is completed or fails. Examples: PA approval triggering same-day specialty pharmacy outreach to confirm shipment timeline; hub case closure triggering a check-in call.
At-Risk Signal Triggers
Outreach initiated when behavioral or data signals indicate elevated discontinuation risk. Examples: refill not initiated within 7 days of expected window; patient portal inactive for 30+ days; 2+ side-effect inquiries in a 30-day window.
Life-Event Triggers
Outreach initiated when known life disruptions create treatment risk: insurance change, address change, loss of employment, caregiver change, or travel notification. These signals are rarely captured but are predictive of discontinuation.
7 Failure Modes to Avoid in Patient Engagement Programs
Even well-resourced patient engagement programs fail predictably at the same structural pressure points. Understanding these failure modes is the first step to designing around them.
Failure Mode 1: Optimizing for Enrollment, Not Persistence
Programs measure and reward the metrics they can see — enrollment rates, first-fill rates, welcome kit delivery. Vendors are incentivized for activation. No one owns the 90%.
→ Fix: Redesign vendor contracts to include persistence-based KPIs alongside activation metrics. Add days-on-therapy milestones to hub and pharmacy SLAs.
Failure Mode 2: No Cross-Vendor Handoff Accountability
The patient falls through the gap between the hub and the specialty pharmacy. Both vendors have technically completed their task. No one owns the transition.
→ Fix: Document every cross-vendor handoff. Assign explicit accountability for transition monitoring. Implement automated status triggers at each handoff point.
Failure Mode 3: Reactive Outreach Architecture
Patient support is structured around inbound contact — patients who call get help. Patients who stop calling are invisible until they appear as a 60-day refill gap.
→ Fix: Implement trigger-based proactive outreach workflows for all identified at-risk moments. Outreach should initiate before the risk becomes a discontinuation.
Failure Mode 4: Data Silos Masquerading as Integration
Each vendor has a dashboard. The brand team reviews four dashboards in separate meetings. No one has a unified patient-level view.
→ Fix: Design cross-vendor data architecture with shared patient identifiers and unified journey visibility. Prioritize integration between hub, pharmacy, and digital platform data at minimum.
Failure Mode 5: SDOH Blind Spots
Commercial patient engagement programs assume patients who are enrolled and filled are 'active.' Real-world patients may be struggling with transportation, housing, or caregiver changes that will drive discontinuation.
→ Fix: Incorporate SDOH screening into intake and follow-up workflows. Build community resource referral pathways into care coordination protocols.
Failure Mode 6: Measuring the Wrong Things
Program scorecards are built from what vendors can easily report — calls handled, materials delivered, copay cards activated. These metrics can be green when patient persistence is declining.
→ Fix: Build a unified measurement framework anchored in persistence outcomes, not activity metrics. Require vendors to contribute data to cross-program analytics.
Failure Mode 7: Adding Vendors Instead of Adding Infrastructure
When a gap is identified, the default response is to add another point solution. Each new vendor solves one problem and creates two new handoff points.
→ Fix: Audit your vendor ecosystem for handoff proliferation before adding new vendors. Often, coordinating existing vendors better produces more patient value than adding new ones.
How Does Your Program Score on the 90/10 Scale?
Take the free 3-minute assessment to identify exactly which of these failure modes your current program is most exposed to — and get a personalized gap analysis.
Take the Free 90/10 AssessmentNext Steps: Building Your Comprehensive Program
Comprehensive patient engagement programs are not built in a single initiative. They are built in layers — starting with diagnostic clarity about where the current program is failing, progressing through ecosystem mapping and outreach redesign, and maturing into cross-vendor data integration and population health management.
Start with the 90/10 Gap Assessment
Before redesigning anything, understand where you stand. The 90/10 Gap Assessment scores your current program on journey visibility, handoff accountability, outreach architecture, data integration, and measurement. You'll leave with a prioritized gap analysis, not a sales conversation.
Conduct a Full Ecosystem Mapping Exercise
Map every vendor, stakeholder, and handoff point in your patient ecosystem using the 5-step methodology above. This diagnostic typically surfaces 3–5 high-priority handoff failures that can be addressed through protocol changes alone — before any technology investment.
Redesign Your Highest-Risk Outreach Gaps
Use your intervention gap map to prioritize outreach workflow redesign. Start with your highest-volume, highest-risk moments: first refill window, post-handoff follow-up, and the 90-day persistence cliff.
Build the Cross-Vendor Measurement Framework
Before adding new vendors or technology, build the measurement architecture that will let you see whether your current interventions are working. Persistence-based KPIs, cross-vendor patient journey dashboards, and a business case model connected to commercial outcomes.
Integrate AI and Predictive Analytics
Once your ecosystem map, outreach workflows, and measurement framework are in place, AI-powered predictive analytics dramatically amplify their impact — identifying at-risk patients earlier, personalizing outreach timing and channel, and optimizing resource allocation.
If you are evaluating whether The 90/10 Framework is the right structured program to guide this work for your brand, explore the program overview here to discuss your specific patient ecosystem and therapy area.
This guide was developed by Linked Patient Learning, founded by a 22-year pharmaceutical industry veteran who has activated more than 200,000 patients across rare disease programs in the U.S. The 90/10 Framework is Linked Patient Learning's proprietary patient engagement program architecture for biopharma companies seeking to address the full patient journey, not just activation. For questions or to explore how this framework applies to your program, contact info@linkedpatientlearning.com.